Aberrant bone density in aging mice lacking the adenosine transporter ENT1

Area of Science:

• Biomedical Science
• Bone Biology
• Pharmacology

Background:

• Adenosine is a key regulator of bone production and resorption.
• Type 1 equilibrative nucleoside transporter (ENT1) mediates adenosine transport and is widely expressed.
• The role of ENT1 in bone remodeling and adenosine signaling remains largely uncharacterized.

Purpose of the Study:

• To investigate the impact of ENT1 deletion on bone density and remodeling.
• To elucidate the contribution of ENT1-mediated adenosine signaling in bone homeostasis.
• To identify potential therapeutic targets for bone disorders.

Main Methods:

• Utilized X-ray, dual-energy X-ray absorptiometry (DXA), and micro-computerized tomography (micro-CT) for bone density analysis.
• Assessed mRNA expression of tartrate-resistant acid phosphatase (TRAP), an osteoclast marker.
• Compared ENT1 null mice with wild-type littermates.

Main Results:

• ENT1 null mice exhibited reduced bone density and bone mineral density in the spine and femur.
• Increased TRAP mRNA expression was observed in long bones of ENT1 null mice, indicating heightened osteoclast activity.
• Aged ENT1 null mice showed deficits in motor coordination and locomotor activity.

Conclusions:

• ENT1 plays a significant role in maintaining lumbar spine and femur bone density.
• ENT1-regulated adenosine signaling is essential for proper bone remodeling and homeostasis.
• Targeting ENT1 may offer a novel therapeutic strategy for bone-related disorders.